Michael Case, MS | Psychiatrist.com

Original Research

Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study

May 17, 2011

Vicki Poole Hoffmann, Michael Case, Jennie G. Jacobson

Original Research

Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies

February 23, 2010

Mauricio Tohen, Michael Case, Madhukar H. Trivedi, et al

Original Research

An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression

March 10, 2009

Madhukar H. Trivedi, Michael E. Thase, Olawale Osuntokun, et al

Original Research

A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

February 15, 2007

Michael E. Thase, Sara A. Corya, Olawale Osuntokun, et al

Original Research

Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance

October 14, 2005

Richard C. Shelton, Douglas J. Williamson, Sara A. Corya, et al

Original Research

Analyses of Treatment-Emergent Mania With Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression

May 15, 2005

Sara A. Corya, Lori L. Altshuler, Terence A. Ketter, et al